Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Payables (2016 - 2025)

Surgery Partners' Payables history spans 12 years, with the latest figure at $208.7 million for Q4 2025.

  • For Q4 2025, Payables changed 0.0% year-over-year to $208.7 million; the TTM value through Dec 2025 reached $208.7 million, changed 0.0%, while the annual FY2025 figure was $208.7 million, 0.0% changed from the prior year.
  • Payables for Q4 2025 was $208.7 million at Surgery Partners, up from $174.6 million in the prior quarter.
  • Across five years, Payables topped out at $208.7 million in Q4 2024 and bottomed at $96.0 million in Q1 2021.
  • The 5-year median for Payables is $150.2 million (2022), against an average of $151.7 million.
  • The largest annual shift saw Payables decreased 10.11% in 2021 before it skyrocketed 32.32% in 2024.
  • A 5-year view of Payables shows it stood at $124.9 million in 2021, then increased by 21.38% to $151.6 million in 2022, then increased by 13.32% to $171.8 million in 2023, then increased by 21.48% to $208.7 million in 2024, then changed by 0.0% to $208.7 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Payables are $208.7 million (Q4 2025), $174.6 million (Q3 2025), and $174.9 million (Q2 2025).